全文获取类型
收费全文 | 2309篇 |
免费 | 145篇 |
国内免费 | 61篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 90篇 |
妇产科学 | 34篇 |
基础医学 | 259篇 |
口腔科学 | 55篇 |
临床医学 | 215篇 |
内科学 | 594篇 |
皮肤病学 | 78篇 |
神经病学 | 77篇 |
特种医学 | 335篇 |
外科学 | 255篇 |
综合类 | 38篇 |
预防医学 | 192篇 |
眼科学 | 21篇 |
药学 | 110篇 |
中国医学 | 7篇 |
肿瘤学 | 153篇 |
出版年
2023年 | 13篇 |
2022年 | 29篇 |
2021年 | 36篇 |
2020年 | 36篇 |
2019年 | 49篇 |
2018年 | 69篇 |
2017年 | 38篇 |
2016年 | 35篇 |
2015年 | 49篇 |
2014年 | 49篇 |
2013年 | 84篇 |
2012年 | 76篇 |
2011年 | 77篇 |
2010年 | 74篇 |
2009年 | 90篇 |
2008年 | 77篇 |
2007年 | 127篇 |
2006年 | 102篇 |
2005年 | 85篇 |
2004年 | 70篇 |
2003年 | 61篇 |
2002年 | 66篇 |
2001年 | 58篇 |
2000年 | 52篇 |
1999年 | 60篇 |
1998年 | 77篇 |
1997年 | 85篇 |
1996年 | 109篇 |
1995年 | 63篇 |
1994年 | 59篇 |
1993年 | 57篇 |
1992年 | 25篇 |
1991年 | 27篇 |
1990年 | 36篇 |
1989年 | 48篇 |
1988年 | 44篇 |
1987年 | 39篇 |
1986年 | 66篇 |
1985年 | 45篇 |
1984年 | 13篇 |
1983年 | 22篇 |
1982年 | 16篇 |
1981年 | 13篇 |
1980年 | 11篇 |
1979年 | 9篇 |
1978年 | 16篇 |
1977年 | 13篇 |
1976年 | 13篇 |
1975年 | 16篇 |
1970年 | 7篇 |
排序方式: 共有2515条查询结果,搜索用时 15 毫秒
1.
2.
Tissue-specific regulation of pyroglutamate aminopeptidase II activity by thyroid hormones 总被引:2,自引:0,他引:2
Among the enzymes capable of degrading thyrotropin-releasing hormone (TRH) in vitro, two pyroglutamate aminopeptidases (PGA) are specific for TRH: thyroliberinase, a seric enzyme and PGAII, a membrane-bound peptidase. The effect of thyroid hormone status on the activity of these enzymes was evaluated in serum and various tissues. Only in adenohypophysis, triiodothyronine treatment increased PGAII to 376% of control; hypothyroidism produced the reverse effect (decrease to 23% of control). As previously reported, similar changes were observed for thyroliberinase. TRH degradation at the adenohypophysis level may participate in the negative feedback control of thyroid hormones. 相似文献
3.
4.
Estrella Fernández Fabrellas Luis Almenar Bonet Silvia Ponce Pérez José Antonio Moro López Rafael Blanquer Olivas Antonio Salvador Sanz 《Archivos de bronconeumologia》2009,45(4):173-180
Introduction and objectiveWhen sleep apnea-hypopnea syndrome (SAHS) and cardiovascular disease occur concurrently, prognosis is affected. Echocardiography can detect structural cardiac abnormalities but using this technique in all patients would place a heavy burden on resources. The objective of this study was to investigate whether the N-terminal fraction of brain natriuretic peptide (NT-proBNP) can be used as a marker for silent heart disease.Patients and methodsNT-proBNP concentration was measured in the 114 consecutive patients with SAHS who underwent echocardiography before starting treatment. Left and right ventricular systolic and diastolic function, as well as structural abnormalities, were studied. Correlations between NT-proBNP concentration and the abnormalities detected were investigated. A receiver operating characteristics (ROC) curve was plotted for NT-proBNP concentration and cardiac abnormalities.ResultsData for 98 patients were finally analyzed. NT-proBNP concentration was significantly correlated with ventricular septal thickness (r=0.63), posterior wall thickness (r=0.45), and left ventricular enddiastolic diameter (r=0.51) (P<.0001 for all correlations). The area under the ROC curve was significant (0.870; 95% confidence interval, 0.801-0.939; P<.0001). Assuming that specificity would be more useful for clinical practice, we calculated that NT-proBNP concentrations below 100 and 200 pg/mL could rule out structural abnormalities with a reliability of 90% and 100%, respectively.ConclusionsNT-proBNP concentration was strongly correlated with echocardiographic abnormalities and so could be a useful tool for identifying patients who should be referred to the cardiologist. 相似文献
5.
6.
Carmen Guillén Ponce María Pilar Garrido López María José Molina Garrido Gema Muñoz Molina Alfredo Carrato 《Clinical & translational oncology》2007,9(1):53-55
Pituitary metastases of solid tumours are infrequent, specially as a first manifestation. When they happen, they are usually
due to breast or lung cancer and are asymptomatic or produce diabetes insipidus. It is very strange that they produce hormonal
deficiency.
We present a case report of a bronchogenic adenocarcinoma in a 65-year-old man which began with panhypopituitarism, diabetes
insipidus and visual alterations. Magnetic resonance imaging revealed a large sellar mass, with clivus infiltration and invading
the right cavernous sinus. The biopsy result was adenocarcinoma metastases from lung cancer. 相似文献
7.
8.
9.
Leonidas JC; Berdon WE; Valderrama E; Neveling U; Schuval S; Weiss SJ; Hilfer C; Godine L 《Radiology》1996,198(2):377
10.
S Ponce G Orive R M Hernández A R Gascón J M Canals M T Mu?oz J L Pedraz 《Journal of controlled release》2006,116(1):28-34
Alginates are the most employed biomaterials for cell encapsulation due to their abundance, easy gelling properties and apparent biocompatibility. However, as natural polymers different impurities including endotoxins, proteins and polyphenols can be found in their composition. Several purification protocols as well as different batteries of assays to prove the biocompatibility of the alginates in vitro have been recently developed. However, little is known about how the use of alginates with different purity grade may affect the host immune response after their implantation in vivo. The present paper investigates the long-term functionality and biocompatibility of murine erythropoietin (EPO) secreting C2C12 cells entrapped in microcapsules elaborated with alginates with different properties (purity, composition and viscosity). Results showed that independently of the alginate type employed, the animals presented elevated hematocrit levels until day 130, remaining at values between 70-87%. However, histological analysis of the explanted devices showed higher overgrowth around non-biomedical grade alginate microcapsules which could be directly related with higher impurity content of this type of alginate. Although EPO delivery may be limited by the formation of a fibrotic layer around non-biomedical grade alginate microcapsules, the high EPO secretion of the encapsulated cells together with the pharmacodynamic behaviour and the angiogenic and immune-modulatory properties of EPO result in no direct correlation between the biocompatibility of the alginate and the therapeutic response obtained. 相似文献